Vimarsana
Biggest News Aggregation in the World

Intermune Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Intermune Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Intermune Inc Today - Breaking & Trending Today

Lineage Cell Therapeutics : NOTICE OF ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON JUNE 11, 2024, PROXY - Vimarsana News

Lineage Cell Therapeutics : NOTICE OF ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON JUNE 11, 2024, PROXY

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Schedule 14A Information ...

MannKind Announces CFO Transition - Vimarsana News

MannKind Announces CFO Transition

Steven B. Binder announces planned retirement and is appointed Executive Vice President, Special Projects, effective April 22, 2024, through Decem...

Roche to buy bowel drugmaker Telavant for $7.1 billion – Indianapolis Business Journal - Vimarsana News

Roche to buy bowel drugmaker Telavant for $7.1 billion – Indianapolis Business Journal

Roche has come under pressure to improve its pipeline with medicines it can commercialize soon as a windfall of revenue from products used in the COVID-19 pandemic comes to an end.

Source: ibj.com
Roche to buy maker of bowel disease drug - Vimarsana News

Roche to buy maker of bowel disease drug

Roche Holding AG will pay $7.1 billion to acquire Telavant Holdings Inc., a developer of a promising therapy for treating inflammatory bowel disease, in a bid to shore up its pipeline of experimental medicines.

How Jack Smith May Charge Trump PAC with Fraudulent Fundraising Within the Bounds of First Amendment - Vimarsana News

How Jack Smith May Charge Trump PAC with Fraudulent Fundraising Within the Bounds of First Amendment

Special Counsel Jack Smith could charge Donald Trump with federal wire fraud for his fundraising off of the Big Lie.